Author(s):
Chinmaya Keshari Sahoo, Amiyakanta Mishra, Amaresh Prusty, S. Ram Mohan Rao, Jimidi Bhaskar
Email(s):
sahoo.chinmaya83@gmail.com
DOI:
10.52711/0974-360X.2021.00456 
Address:
Chinmaya Keshari Sahoo1*, Amiyakanta Mishra1, Amaresh Prusty1, S. Ram Mohan Rao2, Jimidi Bhaskar3
1Department of Pharmaceutics, College of Pharmaceutical Sciences,
(Affiliated to Biju Patnaik University of Technology), Puri, Odisha.
2Department of Engineering, Mekelle Institute of Technology, Mekelle University, Mekelle, Ethiopia.
3Department of Pharmaceutics, KLR Pharmacy College, Paloncha, Bhadradri Kothagudem, Telangana.
*Corresponding Author
Published In:
Volume - 14,
Issue - 5,
Year - 2021
ABSTRACT:
The present study was undertaken to develop floating tablets of lamivudine. The tablets were prepared by direct compression method. The prepared tablets were evaluated for pre compression parameters, post compression parameters, in vitro drug release study and in vitro buoyancy study. Among the prepared formulations F4 batch show 90.98% drug release in 12 h. The in vitro release kinetics were analyzed for different batches by different pharmacokinetic models such as zero order, first order, Higuchi, and Korsmeyer Peppas. The result of optimized formulation releases drug up to 12 h in a controlled manner and follows Higuchi kinetics. Short term stability study at 40±2ºC/75±5% RH for three months on the best formulation was performed showing no significant changes in thickness, hardness, friability, drug content and in vitro drug release.
Cite this article:
Chinmaya Keshari Sahoo, Amiyakanta Mishra, Amaresh Prusty, S. Ram Mohan Rao, Jimidi Bhaskar. Development and Evaluation of Floating Tablets of Lamivudine. Research Journal of Pharmacy and Technology. 2021; 14(5):2593-7. doi: 10.52711/0974-360X.2021.00456
Cite(Electronic):
Chinmaya Keshari Sahoo, Amiyakanta Mishra, Amaresh Prusty, S. Ram Mohan Rao, Jimidi Bhaskar. Development and Evaluation of Floating Tablets of Lamivudine. Research Journal of Pharmacy and Technology. 2021; 14(5):2593-7. doi: 10.52711/0974-360X.2021.00456 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-5-40
REFERENCES:
1. Presscott LF. The need for improved drug delivery in clinical practice in Novel Drug Delivery and its Therapeutic applications. West Susset, UK: John Wiley and Sons; 1989,1-11.
2. Shweta Arora, Javed Ali, Alka Ahuja, Roop K. Khar, and Sanjula Baboota. Floating Drug Delivery Systems: A Review. AAPS Pharm Sci Tech 2005; 6 (3): E372-E390.
3. Sahoo CK, Rao SRM, Sudhakar M. Development and evaluation of controlled release formulation of lamivudine based on microporous osmotic tablet technology using fructose as osmogen. Indonesian Journal of Pharmacy 2017; 28(3): 168-178.
4. Sirisha VNL, Kumarrao YK, Eswaraiah MC. Formulation and evaluation of lamivudine and zidovudine extended-release tablets. International Journal of Research in Pharmaceutical and Biomedical Sciences 2012;3(4): 1759-1763.
5. Sahoo CK, Rao SRM, Sudhakar M, Bhaskar J. Advances in granulation technology. Research J. Pharm. and Tech. 2016;9(5): 571-580.
6. Cooper J, Gunn C. Powder flow and compaction. In: Carter SJ, editors. Tutorial Pharmacy. New Delhi: CBS publisher and Distributors;1986; 211-33.
7. Satyanarayana K, Sahoo CK, Bhargavi G, Sahoo NK. Formulation and optimization of olanzapine sustained release matrix tablets for the treatment of schizophrenia. Der Pharmacia Lettre 2015;7(4): 266-273.
8. Sunil SA, Srikanth MV, Rao NS, Balaji S, Murthy KVR, Design and evaluation of lornoxicam bilayered tablets for biphasic release. Brajilian Journal of Pharmaceutical Sciences 2012;48(4): 609-619.
9. Panda N, Reddy AV, Reddy GVS, Panda KC. Formulation Design and in vitro Evaluation of Zolmitriptan Immediate Release Tablets using Primojel and AC-Di-Sol. J. Pharm. Sci. and Res. Vol. 7(8), 2015, 545-553.
10. Mina Ibrahim Tadros Controlled release effervescent floating matrix tablets of ciprofloxacin hydrochloride: Development, optimization and in vitro-in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm 2010; 74: 332-39.
11. The USP 26-National Formulary 21 Rockville MD US Pharmacopoeial Convention 2003.
12. Srinivasa Rao M, Madhuri KSN, Vijaya Kumar G Formulation and evaluation of controlled release floating tablets of lamivudine employing HPMC K4M and sodium alginate. Int J Pharm Sci and Res 2013; 4(1): 396-400.
13. Sahoo CK, Rao SRM, Sudhakar M and Kokkula S. The kinetic modeling of drug dissolution for drug delivery systems: an overview. Der Pharmacia Lettre 2015;7(9): 186-194.
14. Costa P, Lobo JMS. Modelling and comparison of dissolution profiles. European J of Pharmaceutical Sciences 2001; 13:123-133.
15. ICH harmonized tripartite guideline, Stability testing of new drug substance and product.Q1A (R2). Federal Register 2003; 68: 65717-18.